Analyst Ratings for Aytu Biosciences (AYTU)
AYTU Rating Summary
AYTU Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $5.00 (Maxim Group)
- Average: $12.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.50 (+311.2%)
* Over Last 12-Mos
Rating Score: 10 / 10 Percentile Rank: 95%
Rating Score: 10 / 10 Percentile Rank: 95%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
8/8/2023 | Maxim Group | N/A | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.69 (3.04) |
79.88% | Details |
3/30/2021 | Cantor Fitzgerald » Updated 2/22/2023 |
Jennifer Kim | New Coverage | Overweight (N/A) |
20.00 (5.00) |
7.71 (3.04) |
-60.57% | Details |
AYTU Ratings News
- Maxim Group Starts Aytu Biosciences (AYTU) at Buy
- UPDATE: Aytu Biosciences (AYTU) PT Lowered to $5 at Cantor Fitzgerald, "Overweight" Rating Reiterated, Analyst Expects "Upwards Earnings Revisions Should Drive Shares Higher"
- Cantor Fitzgerald Reiterates Aytu Biosciences (AYTU) at Overweight, $11 PT, Sees it as Positive Development Potentially Extending ADHD Franchise Revenue Runway
- See More